Myeloid progenitors in acute non-lymphocytic leukemia: prognostic value in remissionGERHARTZ, H. H; WILMANNS, W.European journal of cancer & clinical oncology. 1986, Vol 22, Num 2, pp 135-140, issn 0277-5379Article

Cloning of early erythroid and mixed myeloid/erythroid human bone marrow progenitor cells: comparison of different sources of burst-promoting activity (BPA)GERHARTZ, H. H; WILMANNS, W.International journal of cell cloning. 1986, Vol 4, Num 6, pp 424-431, issn 0737-1454Article

Detection of minimal residual disease in acute myeloid leukemiaGERHARTZ, H. H; SCHMETZER, H.Leukemia. 1990, Vol 4, Num 7, pp 508-516, issn 0887-6924, 9 p.Article

Immunological phenotyping in situ of myeloid colonies in agar culturesSCHMETZER, H; GERHARTZ, H. H.Experimental hematology. 1987, Vol 15, Num 8, pp 877-882, issn 0301-472XArticle

Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitroBRAUN, S; GERHARTZ, H. H; SCHMETZER, H. M et al.Annals of hematology (Print). 2000, Vol 79, Num 7, pp 363-373, issn 0939-5555Article

GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitroSCHMETZER, H. M; GERHARTZ, H. H; WILMANNS, W et al.Annals of hematology (Print). 1999, Vol 78, Num 10, pp 449-455, issn 0939-5555Article

Detection of acute myeloid leukemic cells in complete remission and in extramedullary sites by clonal analysesSCHMETZER, H. M; WILMANNS, W; GERHARTZ, H. H et al.Acta haematologica. 1996, Vol 96, Num 2, pp 83-87, issn 0001-5792Article

Reduction of infection rates in cancer patients associated with the use of haematopoietic growth factorsGERHARTZ, H. H.European journal of cancer. Part A. 1993, Vol 29, pp S14-S17, SUP3Conference Paper

Acute myeloid leukemia (AML) can be oligoclonalSCHMETZER, H. M; GERHARTZ, H. H.Leukemia. 1993, Vol 7, Num 12, pp 1965-1970, issn 0887-6924Article

IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas : a pilot studyWALTHER, J; WILMANNS, W; GERHARTZ, H. H et al.Annals of hematology (Print). 1993, Vol 66, Num 3, pp 135-137, issn 0939-5555Conference Paper

D-penicillamine-induced agranulocytosis : hematological remission upon treatment with recombinant GM-CSFPETRIDES, P. E; GERHARTZ, H. H.Zeitschrift für Rheumatologie (Print). 1991, Vol 50, Num 5, pp 328-329, issn 0340-1855Article

Chemotherapy dose and survival in advanced Hodgkin's diseaseGERHARTZ, H. H; BEYKIRCH, M; HILLER, E et al.Acta haematologica. 1993, Vol 89, Num 3, pp 137-140, issn 0001-5792Article

Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhageGERHARTZ, H. H; SAUERBRUCH, T; WEINZIERL, M et al.Endoscopy (Stuttgart). 1984, Vol 16, Num 4, pp 129-130, issn 0013-726XArticle

Allogenic transplantation of blood stem cells concentrated by density gradientsGERHARTZ, H. H; NOTHDURFT, W; CARBONELL, F et al.Experimental hematology. 1985, Vol 13, Num 2, pp 136-142, issn 0301-472XArticle

In vivo differentiation of leukaemic blasts and effect of low dose ara-C in a marrow grafted patient with leukaemic relapseMITTERMÜLLER, J; KOLB, H. J; GERHARTZ, H. H et al.British journal of haematology. 1986, Vol 62, Num 4, pp 757-762, issn 0007-1048Article

Clonality analysis as a tool to study the biology and response to therapy in myelodysplastic syndromesSCHMETZER, H. M; POLECK, B; MITTERMÜLLER, J et al.Leukemia. 1997, Vol 11, Num 5, pp 660-666, issn 0887-6924Article

A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemiaGERHARTZ, H. H; MARCUS, R; FIERE, D et al.Leukemia. 1994, Vol 8, Num 1, pp 16-23, issn 0887-6924Article

Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromesSCHMETZER, H. M; POLECK, B; DUELL, T et al.Annals of hematology (Print). 2000, Vol 79, Num 1, pp 20-29, issn 0939-5555Article

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF)GERHARTZ, H. H; MARCUS, R; HOFFBRAND, A. V et al.Infection. Supplement. 1992, Vol 20, Num 2, pp S116-S123, issn 0173-2129Article

Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemiaSCHMETZER, H. M; BRAUN, S; WIESNER, D et al.Acta haematologica. 2000, Vol 103, Num 3, pp 125-134, issn 0001-5792Article

Enhanced endogenous leukotriene biosynthesis in patients treated with granulocyte-macrophage colony-stimulating factorDENZLINGER, C; KAPP, A; GRIMBERG, M et al.Blood. 1990, Vol 76, Num 9, pp 1765-1770, issn 0006-4971Article

Spontaneous Epstein-Barr virus transformed B-cell line sharing the identical immunoglobulin gene rearrangement with acute myeloid leukemiaGERHARTZ, H. H; BARTRAM, C. R; RAGHAVACHAR, A et al.Blood. 1989, Vol 73, Num 3, pp 684-687, issn 0006-4971Article

Differential activation of the endogenous leukotriene biosynthesis by two different preparations of granulocyte-macrophage colony-stimulating factor in healthy volunteersDENZLINGER, C; TETZLOFF, W; GERHARTZ, H. H et al.Blood. 1993, Vol 81, Num 8, pp 2007-2013, issn 0006-4971Article

Low-dose ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromesGERHARTZ, H. H; VISANI, G; SIZOO, W et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, pp 36-37, issn 0268-3369, 2 p., suppl. 3Conference Paper

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumorsBOKEMEYER, C; HARSTRICK, A; SCHÖFFSKI, P et al.Seminars in oncology. 1998, Vol 25, Num 2, pp 24-32, issn 0093-7754, SUP4Conference Paper